Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2008

View Archived Issues

Stanford University identifies two potential drug targets to treat malaria

Transcutaneous immunization effective in protecting against enterohemorrhagic E. coli infection

New antiinfective agents described in recent GSK patents

Activation of the unfolded protein response central in the pathogenesis of Charcot-Marie-Tooth 1B

Trophos receives grant to evaluate TRO-19622 in Parkinson's disease

Cogentus appoints Scientific Steering Committee for CGT-2168 phase III clinical program

University of Adelaide awarded AUD 2 million grant for five-year hepatitis C project

Toyama Chemical initiates phase II trial of T-5224 for rheumatoid arthritis

Takeda profiles Q3 developments

Risperidone long-acting injection delays relapse in bipolar disorder

Studies show aripiprazole efficacy in pediatric psychological disorders

Recent patents impart novel therapeutic agents for respiratory disorders

New antiinfective agents reported in recent patents

OctoPlus and Biolex commence phase IIa Locteron study in hepatitis C

MGCD-0103 receives orphan drug designation for acute myelogenous leukemia

Merck KGaA and Novo Nordisk disclose new diabetes compounds in recent patent literature

Pharmacopeia selects novel chemokine receptor antagonist for development

TopoTarget clarifies collaboration with Leo Pharma

Sosei commences AD-923 phase III studies in Europe

Promising interim results reported from phase III Zadaxin trial in hepatitis C

Symbollon Pharmaceuticals completes phase III trial of IoGen for fibrocystic breast disease

Solstice Neurosciences responds to FDA early communication regarding Myobloc for cervical dystonia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...